ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TATE Tate & Lyle Plc

572.50
-30.50 (-5.06%)
Share Name Share Symbol Market Type Share ISIN Share Description
Tate & Lyle Plc LSE:TATE London Ordinary Share GB00BP92CJ43 ORD 29 1/6P
  Price Change % Change Share Price Shares Traded Last Trade
  -30.50 -5.06% 572.50 1,100,895 16:35:13
Bid Price Offer Price High Price Low Price Open Price
576.00 577.00 610.00 566.50 597.50
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Flavoring Extract,syrup, Nec 1.65B 188M 0.4221 13.65 2.69B
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:13 O 18 575.00 GBX

Tate & Lyle (TATE) Latest News (8)

Tate & Lyle (TATE) Discussions and Chat

Tate & Lyle Forums and Chat

Date Time Title Posts
22/5/202519:07Tate and Lyle Graph's and Charts4,061
26/11/202116:20TATE Charts38
22/5/201913:29Tate & Lyle FY Preview 23.05.19-
03/7/201409:18Darren Sinden bullish on Tate & Lyle PLC live on TipTV-
10/9/201305:52TATE sweet & sour103

Add a New Thread

Tate & Lyle (TATE) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
15:54:17573.001374.49O
15:35:13572.50449,2192,571,778.78UT
15:29:58576.0015.76AT
15:29:58576.0084483.84AT
15:29:58576.002061,186.56AT

Tate & Lyle (TATE) Top Chat Posts

Top Posts
Posted at 22/5/2025 09:20 by Tate & Lyle Daily Update
Tate & Lyle Plc is listed in the Flavoring Extract,syrup, Nec sector of the London Stock Exchange with ticker TATE. The last closing price for Tate & Lyle was 603p.
Tate & Lyle currently has 445,429,642 shares in issue. The market capitalisation of Tate & Lyle is £2,565,674,738.
Tate & Lyle has a price to earnings ratio (PE ratio) of 13.65.
This morning TATE shares opened at 597.50p
Posted at 22/5/2025 09:47 by whites123
Reading the above I do question the valuation as CP has now added value to the tune of £1.8 Billion.

CP Kelco was acquired for $1.8 billion (around £1.4 billion), and its integration into Tate & Lyle strengthens the company’s specialty ingredients portfolio and future earnings potential, then logically, that should raise the overall valuation of Tate & Lyle beyond the original £2.8 billion rumoured bid.

In fact, using simple arithmetic, a £2.8–£3 billion valuation might now understate the true worth of the combined business, particularly given market multiples for specialty food ingredient companies are typically higher than for legacy commodities.

The original £2.8bn figure reflected Tate & Lyle prior to CP Kelco’s impact.

The £3bn rumour is either outdated or conservative, or being deliberately floated to test market reaction.

Advent may still be finalising a more competitive valuation that reflects the enhanced business profile post acquisition.

I would even argue that any credible takeover would now need to factor in a control premium plus the strategic uplift from CP Kelco, which could easily push the price significantly higher.

All I know is that the share price isnt reflecting any of this.
Posted at 22/5/2025 09:27 by whites123
Rumours Intensify Around Advent’s Takeover of Tate & Lyle

Market speculation is mounting around a potential takeover of Tate & Lyle by U.S. private equity giant Advent International. According to credible reports, Advent has been preparing a formal bid since late 2024, when Tate & Lyle’s share price surged above £8.00 on news of their interest. Initial expectations valued the bid at over £2.8 billion.

Now, sources suggest the deal is entering its final stages of preparation and internal consideration. The rumoured offer has reportedly grown in scale, with current estimates topping £3 billion — a reflection of both Tate & Lyle’s strategic transformation and strong market positioning in healthier food ingredients.

While neither party has officially commented, the market is watching closely. A formal announcement, if made, could mark one of the most significant moves in the UK food sector this year.
Posted at 22/5/2025 08:49 by wad collector
Gotta be patient with TATE I reckon.
Posted at 22/5/2025 07:45 by whites123
Tate has just wrapped up a big transformation. They’re no longer just a sugar company, they’re now a global player helping food companies make healthier, tastier products.

They bought CP Kelco in late 2024, and this is already paying off:

Profits (EBITDA) are up 5% across the enlarged group.

Cash flow is strong at £190 million, meaning the company generates solid money after expenses.

They’re innovating, winning new business, and improving margins.

A £216m share buyback and increased dividend show confidence and shareholder focus.

Debt is under control and better than expected.

Despite a slight dip in revenue due to lower raw material prices (which they passed on to customers), profits and efficiency improved, a sign of good management and a resilient business.

1. Transformation complete – growth ahead: Tate has shifted into a high-margin, health-focused food solutions business. This positions them perfectly for the global demand for healthier food.

2. Acquisition already working: CP Kelco is outperforming expectations, adding scale, innovation, and synergy potential (£50m+ in cost savings targeted).

3. Cash is flowing: With £190m free cash flow and solid earnings, Tate can invest, pay dividends, and reduce debt — all signs of a strong company.

4. Market leadership in “MouthfeelR21;: This means they’re critical in helping brands make low-sugar, high-fiber foods taste good — a must-have in modern food production.

5. Upside not priced in: At current levels, the stock doesn’t yet reflect the growth potential from CP Kelco integration and future synergies.

In my opinion a return to +£8.00 per share is not just a possibility, it’s a probability. With strong fundamentals, execution, and industry positioning, this price level reflects fair value for the new, transformed Tate & Lyle.
Posted at 21/5/2025 08:56 by whites123
TATE presents a compelling investment opportunity ahead of its full-year results announcement tomorrow. The company's strategic acquisition and integration of CP Kelco have positioned it for significant growth and value creation.

The integration of CP Kelco, operating as one by April 2025, has been executed smoothly, with the combined entity now operating under a unified regional framework encompassing the Americas, Asia Pacific, and EMEA. This consolidation is expected to deliver targeted run-rate cost synergies of US$50 million by the end of the 2027 financial year, with more than 50% anticipated by the end of 2026.

In its pre-close statement, Tate & Lyle indicated that the financial results for the year ended March 31, 2025, are expected to be in line with guidance. Notably, CP Kelco is projected to deliver an increase in EBITDA margin of over 90 basis points, surpassing initial expectations and reinforcing confidence in its phased margin recovery.

Its focus on healthier food and beverage solutions aligns with global consumer trends. The acquisition of CP Kelco enhances its capabilities in providing natural ingredients like pectin and specialty gums, catering to the growing demand for low-sugar and plant-based products.

Given the successful integration of CP Kelco, anticipated cost synergies, and alignment with health-conscious consumer trends, a rebound in Tate & Lyle's share price to £7.00 and above is in my opinion a realistic proposition. The company's strategic initiatives and financial performance position it as a strong buy ahead of the upcoming results announcement.
Posted at 18/5/2025 10:50 by laurence llewelyn binliner
#Pete160, I picked these up in 2022 pre the special payout and consolidation, then bought back the shares I lost and had about 80 pence total return from dividends since, stop losses do have a place, but often stop you out only to watch the share either get a TO or reverse its fortunes through changes in leadership and recover.. :o)

A safe, steady dividend here, the payout has been recovering slowly since 2023, and the merge-co will drive profits, TATE will be just fine as they deliver results and economies of scale hit the bottom line..

22nd this week for the next results and dividend update..
Posted at 18/5/2025 09:47 by pete160
I jumped the gun and ramped up my position when it fell to 700 (falling knife and all that) but have held all the way down because of the points above.
Another share choice of mine which has become a 'long term investment' which I classify all my clangers as - rather than being more ruthless and using a regimented stop loss.
Posted at 18/5/2025 09:18 by laurence llewelyn binliner
#Pete160, 15.04.2025 - The integration is progressing well and as planned, with Tate & Lyle and CP Kelco operating as one combined business from 1 April 2025..

Encouraging to see 500-600 done without a stall inside 2 months..

Synergies are unlikely to be reflected much in the FY results, more the H1, see what we get, looking forward to the results and DPS.. :o)
Posted at 17/5/2025 14:28 by pete160
If Tate disappoints it will get taken out within the next 12 months.
If Tate can show that the integration is going well, the same thing may happen anyway.
It's just a matter of price.
Posted at 17/5/2025 09:31 by laurence llewelyn binliner
Looking forward to results next week, see if the CP Kelco integration is adding value yet, but it will most likely be H1 before we see too much reflected in the numbers..

15.04.205 - Tate & Lyle performed as expected in Q4 and for the year ended 31 March 2025 will be in line with guidance. Excluding CP Kelco and in constant currency, we expect revenue will be 5% lower and EBITDA will be 4% higher..
Tate & Lyle share price data is direct from the London Stock Exchange

Tate & Lyle Frequently Asked Questions (FAQ)

What is the current Tate & Lyle share price?
The current share price of Tate & Lyle is 572.50p
How many Tate & Lyle shares are in issue?
Tate & Lyle has 445,429,642 shares in issue
What is the market cap of Tate & Lyle?
The market capitalisation of Tate & Lyle is GBP 2.69B
What is the 1 year trading range for Tate & Lyle share price?
Tate & Lyle has traded in the range of 460.60p to 848.50p during the past year
What is the PE ratio of Tate & Lyle?
The price to earnings ratio of Tate & Lyle is 13.65
What is the cash to sales ratio of Tate & Lyle?
The cash to sales ratio of Tate & Lyle is 1.56
What is the reporting currency for Tate & Lyle?
Tate & Lyle reports financial results in GBP
What is the latest annual turnover for Tate & Lyle?
The latest annual turnover of Tate & Lyle is GBP 1.65B
What is the latest annual profit for Tate & Lyle?
The latest annual profit of Tate & Lyle is GBP 188M
What is the registered address of Tate & Lyle?
The registered address for Tate & Lyle is 5 MARBLE ARCH, LONDON, W1H 7EJ
Which industry sector does Tate & Lyle operate in?
Tate & Lyle operates in the SUGAR & CONFECTIONERY PRODS sector

Your Recent History

Delayed Upgrade Clock